Insights from GWAS, TWAS, and DEG analysis: CDKN2B-AS1, MAP3K4, and P2RX2-encoded P2X2 receptor identified as potential therapeutic targets for ischemic heart disease in Russian adults and long-living individuals.

Daniel V, Romanova N, Mamchur A, Nartova A, Abushinova G, Ivanov M, Ezhov M, Meshkov A, Gomyranova N, Vasiliev V, Latypov R, Vorobieva Y, Gostischeva O, Chubykina U, Gurtsiev T, Aksenova Y, Komarova M, Kumar N, Maralova E, Shingaliev A, Mitrofanov S, Yudin V, Keskinov A, Tkacheva O, Skvortsova V, Boytsov S, Yudin S, Kashtanova D

Open source

DOI
10.3389/fcvm.2026.1839477
Published
2026
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1839477,
  title = {Insights from GWAS, TWAS, and DEG analysis: CDKN2B-AS1, MAP3K4, and P2RX2-encoded P2X2 receptor identified as potential therapeutic targets for ischemic heart disease in Russian adults and long-living individuals.},
  author = {Daniel V and Romanova N and Mamchur A and Nartova A and Abushinova G and Ivanov M and Ezhov M and Meshkov A and Gomyranova N and Vasiliev V and Latypov R and Vorobieva Y and Gostischeva O and Chubykina U and Gurtsiev T and Aksenova Y and Komarova M and Kumar N and Maralova E and Shingaliev A and Mitrofanov S and Yudin V and Keskinov A and Tkacheva O and Skvortsova V and Boytsov S and Yudin S and Kashtanova D},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.1839477},
  url = {https://doi.org/10.3389/fcvm.2026.1839477}
}

RIS

TY  - JOUR
TI  - Insights from GWAS, TWAS, and DEG analysis: CDKN2B-AS1, MAP3K4, and P2RX2-encoded P2X2 receptor identified as potential therapeutic targets for ischemic heart disease in Russian adults and long-living individuals.
AU  - Daniel V
AU  - Romanova N
AU  - Mamchur A
AU  - Nartova A
AU  - Abushinova G
AU  - Ivanov M
AU  - Ezhov M
AU  - Meshkov A
AU  - Gomyranova N
AU  - Vasiliev V
AU  - Latypov R
AU  - Vorobieva Y
AU  - Gostischeva O
AU  - Chubykina U
AU  - Gurtsiev T
AU  - Aksenova Y
AU  - Komarova M
AU  - Kumar N
AU  - Maralova E
AU  - Shingaliev A
AU  - Mitrofanov S
AU  - Yudin V
AU  - Keskinov A
AU  - Tkacheva O
AU  - Skvortsova V
AU  - Boytsov S
AU  - Yudin S
AU  - Kashtanova D
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1839477
UR  - https://doi.org/10.3389/fcvm.2026.1839477
ER  - 

APA

V, D., N, R., A, M., A, N., G, A., M, I., M, E., A, M., N, G., V, V., R, L., Y, V., O, G., U, C., T, G., Y, A., M, K., N, K., E, M., A, S., S, M., V, Y., A, K., O, T., V, S., S, B., S, Y., & D, K. (2026). Insights from GWAS, TWAS, and DEG analysis: CDKN2B-AS1, MAP3K4, and P2RX2-encoded P2X2 receptor identified as potential therapeutic targets for ischemic heart disease in Russian adults and long-living individuals.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.1839477

Source records